CD7 is a type I transmembrane glycoprotein with a MW of 40-kD, whose expression level has been found to be significantly upregulated in T-ALL cells compared to normal CD7-positive T cells. This evidence concerns the gene CD7 and acute lymphoblastic leukemia.